生物可吸收植入市场：依材料类型、按应用、按最终用户、按地区

全球生物可吸收植入市场预计到2024年将达到61亿美元，预计2031年将达到108亿美元，2024年至2031年的复合年增长率为8.5%。

图：2024 年按地区分類的生物可吸收植入市场占有率(%)

可生物吸收植入是医疗设备，旨在暂时保留在体内，并在达到预期目的后进行生物分解。由聚乳酸 (PLLA) 和Polyglycolic(PGA) 等聚合物製成的生物可吸收植入随着时间的推移分解并吸收到体内。这减少了移除植入的侵入性手术的需要。与传统永久植入相比，生物可吸收植入具有显着优势，包括较少的应力屏蔽、逐渐吸收以将负荷转移到癒合骨骼，并避免长期併发症。全球生物可吸收植入市场的成长是由心臟病和整形外科疾病的日益流行、外科手术数量的增加、生物可吸收材料相对于永久植入的优越性以及技术进步所推动的。

市场动态：.

全球生物可吸收植入市场的成长主要是由老年人口的增加所推动的，老年人口更容易患心臟疾病和整形外科疾病。据世界卫生组织称，65岁及以上的人口预计将从2010年的5.24亿增加到2050年的近15亿。生物可吸收植入降低了永久性植入相关感染疾病的风险，且无需移除植入。因此，它们比传统植入的需求更高。此外，正在开发先进的可吸收聚合物，其具有适合每种组织癒合过程的客製化降解率，从而推动市场成长。然而，与金属植入相比，生物可吸收植入的成本较高，且低收入国家的认知度较低，可能会阻碍市场成长。持续研究和开发用于软组织修復和药物输送的可吸收植入可能为製造商提供利润丰厚的机会。

本研究的主要特点

• 该报告对全球生物可吸收植入市场进行了详细分析，以 2023 年为基准年估计了预测期内（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球生物可吸收植入市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球生物可吸收植入市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球生物可吸收植入市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球生物可吸收植入市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球生物可吸收植入市场，依材料类型，2019-2031

• 金属的
• 聚合物

第六章全球生物可吸收植入市场，依应用分类，2019-2031

• 整形外科
• 心血管
• 其他的

第 7 章 全球生物可吸收植入市场，依最终使用者划分，2019-2031 年

• 医院
• 专科诊所
• 门诊手术中心
• 其他的

第八章全球生物可吸收植入市场，按地区，2019-2031

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第9章 竞争格局

• 公司简介
  • Abbott Laboratories
  • Medtronic plc
  • Johnson &Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith &Nephew plc
  • Boston Scientific Corporation
  • Biotronik SE &Co. KG
  • Terumo Corporation
  • Amaranth Medical, Inc.
  • Arthrex, Inc.
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion NV
  • DSM Biomedical
  • WL Gore &Associates, Inc.

第10章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

Global bioresorbable implants market is estimated to be valued at USD 6.10 Bn in 2024 and is expected to reach USD 10.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Figure. Bioresorbable Implants Market Share (%), By Region 2024

Bioresorbable implants are medical devices that are designed to remain in the body temporarily and undergo biodegradation after serving their intended purpose. Made from polymers such as polylactic acid (PLLA) and polyglycolic acid (PGA), bioresorbable implants degrade over time and are absorbed by the body. This alleviates the need for subsequent invasive surgery to remove implants. These offer significant benefits over traditional permanent implants by causing less stress shielding, resorbing gradually to transfer load to healing bone, and avoiding long-term complications. Global bioresorbable implants market growth is driven by growing prevalence of cardiac and orthopedic diseases, rising number of surgeries, advantages of bioresorbable materials over permanent implants, and technological advancements.

MARKET DYNAMICS:

Global bioresorbable implants market growth is primarily driven by rising geriatric population who are more prone to develop cardiac diseases and orthopedic disorders. As per WHO, the number of people aged 65 years and above is expected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Bioresorbable implants reduce the risk of permanent implant-related infections and eliminate the need for implant removal. This boosts their demand over conventional implants. Moreover, advanced resorbable polymers with customized degradation rate are being developed to suit individual tissue healing process, thus, driving the market growth. However, high costs of bioresorbable implants as compared to metal implants and lack of awareness in low-income nations can hamper the market growth. Ongoing R&D to develop resorbable implants for soft tissue repair and drug delivery can offer lucrative opportunities for manufacturers.

Key Features of the Study:

• This report provides in-depth analysis of the global bioresorbable implants market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bioresorbable implants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include DePuy Synthes, Stryker, Smith & Nephew, Zimmer Biomet, Medtronic and Bioretec
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bioresorbable implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioresorbable implants market

Detailed Segmentation-

• By Material Type
  • Metallic
  • Polymer
• By Application
  • Orthopedic
  • Cardiovascular
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Amaranth Medical, Inc.
  • Arthrex, Inc.
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion N.V.
  • DSM Biomedical
  • WL Gore & Associates, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Material Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bioresorbable Implants Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bioresorbable Implants Market, By Material Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Metallic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Polymer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Bioresorbable Implants Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Orthopedic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiovascular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Bioresorbable Implants Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Bioresorbable Implants Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zimmer Biomet Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Smith & Nephew plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amaranth Medical, Inc.
  • Arthrex, Inc.
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion N.V.
  • DSM Biomedical
  • WL Gore & Associates, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact